🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New consensus paper on Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging Read more on doi.org/10.1016/j.jcmg…

Is genetic testing worthy in recurrent pericarditis? Our data suggest it may have a role for young patients with family history, multiple recurrences and inflammatory phenotype. Learn more at 2024 ESC Congress and soon open access on Journal of Cardiovascular Medicine 2024!

Diagnosis, Risk Stratification, and Treatment of Pericarditis Learn more on JAMA: Cremer PC, Klein AL, Imazio M. JAMA. 2024 Sep 5. doi: 10.1001/jama.2024.12935. Epub ahead of print. PMID: 39235771. jamanetwork.com/journals/jama/…

Main novelties of European Guidelines on Infective Endocarditis. Open access on Journal of Cardiovascular Medicine ..

Iniziano oggi ad Udine 2 giornate di aggiornamento cardiologico sulle nuove linee guida cardiologiche 2024…

3 ottobre ore 13.30 – 14.00 JOURNAL CLUB GdS CARDIOMIOPATIE E MALATTIE DEL PERICARDIO Programma in allegato Link per iscriversi: us06web.zoom.us/meeting/regist…

Genetic variants in patients with recurrent pericarditis. Learn more on J Cardiovasc Med (Hagerstown). 2024 Nov 1;25(11):799-804. Open Access.

Genetic variants in patients with recurrent pericarditis : Journal of Cardiovascular Medicine journals.lww.com/jcardiovascula…

Pericardial constrictive syndromes: a neglected cause of reversible heart failure. Learn more on J Cardiovasc Med (Hagerstown). 2024 Dec 1;25(12):811-814 (open access).

Pericardial constrictive syndromes: a neglected cause of... : Journal of Cardiovascular Medicine journals.lww.com/jcardiovascula…

Should we start using colchicine for secondary prevention of MACE in acute and chronic coronary syndromes? Cumulative data of all studies suggests a positive reply. Learn more on 2024 Nov 28. doi: 10.2459/JCM.0000000000001688. Epub ahead of print. Open access.

SCD risk after acute myocarditis with arrhythmic presentation: hunting for risk predictors… learn more on Open Heart (open access).

Outcomes of acute pericarditis with an inflammatory phenotype The inflammatory phenotype of presentation of acute pericarditis is associated with an increased risk of recurrences.Learn more on Int J Cardiol. 2025 Jan 15;423:132945. doi: 10.1016/j.ijcard.2024.132945 (open access).

Duration of Disease and Long-Term Outcomes in Patients With Difficult-To-Treat Recurrent Pericarditis: A Chronic Condition? Learn more on ACR Open Rheumatol. 2025 Jan;7(1):e11776. doi: 10.1002/acr2.11776 (open access).

Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement from ESC Working Group on Myocardial and Pericardial Diseases. Learn more on Eur Heart J. 2025 May 20:ehaf222. doi: 10.1093/eurheartj/ehaf222.

Human intravenous immunoglobulins for recurrent pericarditis. A last option for medical therapy of recurrent pericarditis: learn more on Eur J Prev Cardiol. 2025 Apr 28:zwaf250. doi: 10.1093/eurjpc/zwaf250.

Comparative Efficacy and Safety of Colchicine and Anti-Interleukin-1 Agents in Recurrent Pericarditis: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials Learn more on J Am Heart Assoc. 2025 Jun 23:e041007. doi: 10.1161/JAHA.125.041007. Epub ahead of print.

Colchicine for prevention of major adverse cardiovascular events: myth or reality? Lear more on J Cardiovasc Med (Hagerstown). 2025 Jun 6. doi: 10.2459/JCM.0000000000001744. Epub ahead of print. PMID: 40530569.

Inflammasome and ventricular arrhythmogenesis: Pathogenic interplay and potential targets on the horizon Learn more on Trends Cardiovasc Med. 2025 Jun 11:S1050-1738(25)00077-5. doi: 10.1016/j.tcm.2025.05.006. Epub ahead of print. PMID: 40513627.

Scoring Systems for Pericarditis: A Step Toward Structured Risk Stratification. Learn more on Current Cardiology Reports (2025) 27:101. doi.org/10.1007/s11886…